Press
Releases
|
Genesis Biofuel Announces Advisory Board
Appointment
Boulder, Colorado-August 25, 2011- Genesis Biofuel,
Inc, a designer and builder
of carbon sequester and algal biodiesel refineries, today announces the appointment of Jennifer M.
McCallum, Ph.D. Esq. to the Genesis Biofuel Advisory Board.
Jennifer is a biotechnology patent attorney with a Ph.D. in
Biotechnology from Colorado State University and a J.D. from the University of Colorado. After
working at two different law firms, Jennifer opened her own biotechnology patent practice in Erie,
Colorado. She has received numerous awards and accolades including a 2008 Congressional Medal of
Distinction, and an appointment by then Colorado Governor Owens to the Biotechnology Council for
the State of Colorado. The Denver Business Journal voted Jennifer one of the 40 top business
leaders under the age of 40, and named her Outstanding Woman in Business in the Professional
Services Category in 2004. Jennifer has received four appointments as the Vice-Chair of the
American Bar Association’s Committee on Bioethics, and she was one of seven attorneys sponsored in
2006 by the U.S. Supreme Court. The McCallum Law Firm, P.C. was recently voted one of the 25 top
women-owned businesses in Colorado for the second year in a row. Jennifer was also named one of the
2009 Rising Stars in the US legal field by Super Lawyers.
Jennifer is currently assisting with the development of
nanotechnologies, in particular, development of the next generation sequencing of devices for DNA,
RNA and a protein that has been featured in Genetic Engineering News. Jennifer’s firm represents
biotechnology, pharmaceutical and medical device companies; several renewable energy companies,
financial entities of many types, such as venture capital groups and investment banks and
universities. She also works overseas on a number of client projects.
Harvey A. Dorren, President & CEO of Genesis Biofuel, Inc.
stated, “We are extremely fortunate to have someone with the credentials and expertise of Ms.
McCallum on our Advisory Board. Her insight and expertise will be invaluable, especially in the
patent and international marketplace, as we continue our endeavors to save the planet, one cement
plant at a time.”
Concentrating on the cement industry, Genesis Biofuel, Inc.
sequesters CO2 directly from manufacturing plants, greatly reducing the greenhouse gas emissions
from these facilities. In addition, the Genesis refineries utilize these gases to produce B100
Biodiesel which is used to meet customer equipment needs while producing a marketable surplus.
|
|
Genesis Biofuel Shareholders Approve Direct
Public Offering
Boulder, Colorado-May 13, 2011- Genesis Biofuel,
Inc., a designer and builder of carbon sequester and algal biodiesel today announced that at last
nights Annual Shareholders Meeting, the attending shareholders unanimously approved the company’s
plans for a Direct Public Offering.
Genesis will initiate a direct public offering (DPO) of common stock
to raise $1,000,000-$5,000,000. The DPO would give Genesis a listing on the Nasdaq OTCBB
(over-the-counter) stock exchange, and would lead to more flexibility for investor stock trading.
With this status Genesis will be able to advertise the offering to the public. The current status
of the Company limits the scope of the offering and has investor restrictions.
In order to secure operation funds to complete the DPO, Genesis is
seeking an additional $170,000, with the minimum investment being $1,000. For those who invest
before July 15, 2011, this investment will be common stock @ $1.00/share in the pre-DPO company.
When the public offering has been approved by the SEC, each share of this stock will convert to
2.19 shares of the publicly traded Genesis common stock. The conversion occurs because the number
of shares outstanding will be increased. The new common stock will be offered to the public for
$1.00/share. Larger investors in the new company may be offered stock at a discount.
The pre-DPO shares will be restricted, so will not be able to be sold
for a period of six months after the date Genesis stock begins trading. While the initial value of
a $1,000 investment will convert to $2,193 of new Genesis stock at the time of the initial
offering, the Company cannot predict the direction of the stock value after the public
offering.
The initial $500K to $1 million raised in the public offering will be
used for ongoing marketing and operating activities, along with construction of a demonstration
laboratory. This facility will consist of 24 photobioreactors (PBR’s) and testing equipment. After
harvesting, the algae would be sent out to a third party for further processing into biomass and
biodiesel. In addition to its utilization for selection and isolation of algal strains, this lab
would serve as a demonstration of their PBR system and processes, and would be used to attract
further levels of investment and customer participation.
As Genesis is able to raise the next $4,000,000, it will expand the
demo facility to a full-scale algae classification and isolation laboratory that will include
additional PBR’s as well as full instrumentation and staff. This facility will produce unrefined
algal oils and biomass for sampling as well as ASTM fuel quality certification.
Genesis has invested two years in building strong customer relations
with the leading companies in the cement manufacturing industry. There is a need in the cement
industry for the Genesis System. The Algal Biofuel industry is being heralded as one solution to
pollution and transportation fuel issues that the global community faces today.
At this point, Genesis has two cement manufacturers eager to partner
with them to build Biorefineries at one of their facilities. In addition they are in possession of
a Commitment Letter from a subsidiary of Exxon Mobil for the purchase of all biofuel produced.
Harvey A. Dorren, President & CEO of Genesis Biofuel, Inc.
stated, “We are excited to initiate this DPO with the approval of our shareholders and look forward
to moving expediently to move Genesis to the next level..
Focusing on the cement industry, Genesis Biofuel, Inc. sequesters CO2
directly from cement manufacturing plants, greatly reducing the greenhouse gas emissions from these
facilities. In addition, the Genesis refineries utilize these gases to produce both algal Biofuel
and Biomass which can be used to meet customer equipment and fuel burning requirements while
producing a marketable surplus.
|
|
Center T
Advisory Services to Provide Project Financing for Genesis Biofuel,
Inc.
DENVER―October 21,
2010 - Center T Advisory Services, LLC, a project financing and business
consulting practice, today announced it has signed a Memorandum of Agreement with Genesis
Biofuel, Inc., to be the exclusive provider of project financing for Genesis Biofuel, Inc.’s
carbon sequestration algal biodiesel refineries.
"I am extremely pleased to have this agreement with Center T
Advisory Services," said Harvey Dorren, president and CEO of Genesis Biofuel, Inc. "Their ability
to provide project financing for our biodiesel refineries will help accelerate our development
activities."
"We have confidence in Genesis Biofuel’s technology, and combined
with their focus on the cement industry, believe they offer a positive renewable energy
opportunity," added Don Clark, president of Center T Advisory Services, LLC. "Their refineries will
be able to sequester CO2 directly from cement manufacturing plants, greatly reducing the greenhouse
gas emissions from these facilities."
See More Information...
|
|
Genesis Biofuel & Gray Oil Sign Letter of
Intent
Boulder , Colorado-April 22, 2010- Genesis Biofuel, Inc., a designer and
builder of carbon sequester and algal biodiesel refineries and Gray Oil, a distributor of fuels,
lubricants and chemicals located in Ft. Lupton , Colorado today announced that they have signed a
formal Letter of Intent. In this agreement Gray Oil, an Exxon Mobil affiliate, agrees to purchase
all B100 Biodiesel from any Genesis refineries in the Rocky Mountain Region. The agreement also
stipulates that Gray Oil has the right of first refusal for the purchase of B100 from any future
Genesis refineries.
Harvey A. Dorren, President & CEO of Genesis Biofuel, Inc. stated, “We are delighted to be
working with Gray Oil. This agreement provides our customers the assurance that there will be a
buyer for their surplus supplies of Biofuel. In addition Gray will also be in a position to supply
methanol and ethylene glycol to Genesis customers.”
Focusing on the cement industry, Genesis Biofuel, Inc. sequesters CO2 directly from
manufacturing plants. This greatly reduces the greenhouse gas emissions from these facilities. In
addition, the Genesis refineries utilize these gases to produce B100 Biodiesel which is used to
meet customer equipment needs while producing a marketable surplus.
|
Genesis Biofuel Announces Advisory Board
Appointment
Boulder, Colorado-March 18,
2010- Genesis Biofuel, Inc, a designer and builder of
carbon sequester and algal biodiesel refineries, today announces the appointment of Doctor Matthew W.
Posewitz to the Genesis Biofuel Advisory Board.
Dr. Posewitz is an Assistant Professor in the Department of
Chemistry and Geochemistry at the Colorado School of Mines(CSM). He specializes in the areas of
biochemistry, algal physiology, photosynthesis and renewable energy technologies. He received a B.S.
from Willamette University, and a Ph.D. from Dartmouth College. He then went on to postdoctoral
research at the University of Utah, and then the Memorial Sloan Kettering Cancer Research Center in New
York City. In 1999, Dr. Posewitz began investigating algal biofuels technologies at the National
Renewable Energy Laboratory. These research efforts included extensive collaborations with CSM, and in
2003 Dr. Posewitz joined the CSM Environmental Science and Engineering Division as an Assistant
Research Professor. Over the last 5 years, he has received over $1.5 M in research funding, and
published more than 25 research papers in high impact journals.
Harvey A. Dorren, President & CEO of Genesis Biofuel, Inc.
stated, “We are extremely fortunate to have someone with the credentials and expertise of Doctor
Posewitz on our Advisory Board. His insight will be invaluable as we continue our endeavors to save the
planet, one cement plant at a time.”
Concentrating on the Cement Industry, Genesis Biofuel, Inc.
sequesters CO2 directly from manufacturing plants, greatly reducing the greenhouse gas emissions from
these facilities. In addition, the GBI refineries then utilize these gases to produce pure B100
Biodiesel which can either be used to meet customer equipment needs or sold as a marketable
surplus.
|
Genesis Biofuel
to Exhibit at 2010 Cement Industry Technical Conference
Boulder, Colorado-January 20, 2010- Genesis Biofuel, Inc, a
designer and builder of carbon sequester and algal biodiesel refineries, is pleased to announce
that they will be exhibiting at the 2010 IEEE-IAS/PCA Cement Industry Technical Conference in
Colorado Springs, Colorado on March 28th –April 1st. This conference is the premier
annual event for leaders, executives and engineers in the cement industry
This years conference will be emphasizing the pending climate change
legislation and NESHAP rules The best intentions of the new legislation and rules will only become
reality through science, engineering, hard work, and lots of capital investment by cement
companies. The program at the 2010 Conference is geared to aiding cement companies get there
successfully. Governor Bill Ritter of Colorado will be the keynote speaker.
Harvey A. Dorren, President/CEO of Genesis stated: ‘We are excited
about being able to meet with many of the leaders in the cement industry who are not yet aware of
Genesis and introducing them to our solution to their green house gas emission problems
Concentrating on the Cement Industry, Genesis Biofuel, Inc.
sequesters CO2 directly from manufacturing plants greatly reducing the green house gas emissions
from these facilities. In addition, the GBI refineries then utilize these gases and produce pure
B100 Biodiesel which can either be used to meet customer equipment requirements or sold as a
marketable surplus.
|
|
|